One month later, the patient presented to the author for the first time ; the visit occurred during one ofher symptomfree periods. Oth er aspects ofher medical history incl uded hypercholestero lem ia and a hysterectomy 9 yea rs earlier.
In add ition to triamterene HCTZ , she was taking estrogen and Lipoflavonoid.
Tuning fork tes ting identified a low-tone hearing loss in the left ear. The patient also had difficulty perfo rming the sharpened tand em Romberg test. Audio logy ofthe left ear detected a mild sensorineural hearing loss (SNHL) at the midtones and a moderate SNHL at 6 and 8 kHz. Her speech reception threshold on the left was 20 dB, and her speech discrimination score was 100% at 60 dB.
Electronystagmography did not reveal any spontaneous or positional nyst agmus . A 58-year-old woman first presented to the author's office in July 1997. She had a long history of various otologic problems, beginning in 1963 with a 4-day period of tinnitus and aura l fullness in the left ear. A few months later, when she was 3 months into her first pregnancy, she experienced another episode of tinnitus in the left ear, which was accompanied by left-sided hearing loss, rotary vertigo, nausea, and vom iting; this episode lasted several days and resol ved spontaneously. She experienced the same symptoms and resolution dur ing her seventh month of pregn ancy. The same symptom pattern occurred during her seco nd, third , and fourth pregnancies; the recurrence during the fourth pregnancy occurred in 1968.
The patient had remained symptom-free until 1995, when she developed aura l fullness and some intermittent hearing loss in the left ear. The blocked feeling was alleviated by antihistamines.
In March 1997, the woman ex perienced a severe attack whi le at work. This time , her symptoms included decreased hear ing and aural fullness in the left ear and rotary vertigo with nausea and vomiting.Triamterene hydrochlorothiazide (HCTZ) help ed relieve the dizzi ness , but her symptoms recurred twice in May 1997 and once in June . She tried diazepam , but she experienced yet another recurrence, which was accompanied by left-sided tinnit us. She tried dexamethasone and trimethobenzamide, and that helped to some degree. (RVR) on the left, and the simultaneous binaural bithermal test yielded a type 2 response and an RVR left. Sma ll-p ixel, thin-slice computed tomography of the temporal bones detected evide nce of otic capsule otosclerosis without ova l window involvement; this finding was more evident in the left ear.
The metabolic evaluation revealed a fasting blood glucose level of I I I mg/dl, whic h rose as high as 237 mg/d l and did not fall to within the normal range for 4 hours. The patient's total cholesterol level was 316 mg/d l, and her triglycer ide level was 204 mg/dl. The triamterene HCTZ and Lipoflavono id were discontinued because of their effects on blood sugar. She was referre d to a nutritionist for coun seling and placed on a modified hypoglycem ic diet low in fat. She was started on pulsed-dose etidronate (a 2-wk cycle every 6 wk) and daily supplemental thera py with calci um and vitamin D.
The patient returne d for follow-up 4 mont hs later in Novem ber 1997 and reported no spe lls of vertigo or hearing symptoms since the previous visit. Her etidronate regimen was conti nued with 8-week cyc les. She returned 7 mont hs later in June 1998 and reported that she had experienced one isolated spell 2 months earlier that had lasted 4 to 5 hours . She had not been fully compliant with her dietary regimen. Her etidronate regimen was extended in 13-week cycles, and fluoride was added .
In September 1998, her left ear became blocked and she noted some fluctuation in her hearing. One mont h later, she had an episode in which she was unable to focus her eyes whi le driving; she also expe rienced imba lance while wa lking, as we ll as nausea and vomiting. At this time, she was sti ll not following her diet. A moderate flat hearing loss was detected in the left ear.
In January 1999, the patient experienced wha t has turn ed out to be her final spell; this episode was of shorter duration and seve rity. Her hearin g in the left ear has continued to fluct uate . In June 2005, she remained free of dizziness. She continues to have difficulty adhering to her diet, and she has also developed non-insulin-dependent diabetes. Her otosc leros is is being treated with risedronate 30 mg twice weekly; this drug is stopped for 2 weeks every 13 weeks and replaced with etidronate at 400 mg/day. She continues taking supplemental calcium, vitamin D, and fluoride daily.
This 42-year history illustrates the effect that the reproductive hormones had in stimulating what eventually became Meniere's syndrome secondary to otosclerosis. Treatment was directed at the otosclerosis and the metabo lic abnormalities that were discovered duri ng eval uation. The more severe symp tom of dizziness was probably brought under contro l by the otosclerosis-directed treat ment. The hearing loss continued to fluctuate, presumably as a result of the effec ts of the diabetes. ALABAMA-GUARANTEE D SALARY. Join a 5-ph ysician SSG in a large, private, not-forprofit hospit al seeking a general ENT-alle rgy or otolo gy a plus. Enjoy light call and very lo w managed car e. Genero us benefits incl ude productio n bon us, maj or ins urance pac kage, (ME, vaca tion , and retirem ent. Located in a communi ty wi th a relax ed lifestyle, very low cost of living, and many cul tu ral and recreational act ivit ies. 
